ISRCTN72553588已完成未知
A randomised controlled trial: two haemoglobin thresholds for transfusion in newborns less than 1000 g birth weight
McMaster University (Canada)0 个研究点目标入组 451 人开始时间: 2007年7月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 451
研究概览
简要总结
2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16939737 2009 Other publications in https://pubmed.ncbi.nlm.nih.gov/19117884/ follow up study (added 08/06/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Infants of birth weight less than 1000 g, either sex
- •2. Postnatal age less than 48 hours
- •3. No transfusion beyond first six hours of life
- •4. Estimated gestational age of 30 completed weeks or less
排除标准
- •1. Infant considered non-viable by attending physician
- •2. Infant has cyanotic congenital heart disease
- •3. Infant's parents known to be opposed to blood transfusion
- •4. Either parent has haemoglobinopathies or congenital anaemias
- •5. Infant has haemolytic disease
- •6. Infant has severe acute haemorrhage, severe shock, severe sepsis with coagulopathy or requires peri-operative transfusion
- •7. Prior treatment with or intention to treat with erythropoietin
研究者
相似试验
已完成
2 期
20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and AnemiaChronic Kidney DiseaseAnemiaNCT01906489Akebia Therapeutics210
已完成
2 期
Heart Failure and AnemiaHeart FailureAnemiaNCT00049985Amgen300
已完成
3 期
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin AlfaSmall Cell Lung CancerNCT00119613Amgen600
终止
不适用
A Randomized Clinical Trial on Hemoglobin Dose and Patient MatchingAnemiaNCT01328262Haukeland University Hospital12
已完成
不适用
The Benefit of Hemodialysis Plus Hemoperfusion on MortalityEnd-stage Renal DiseaseNCT03227770Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1,362